Congestive Heart Failure

Researchers Reverse Damage With Gene Therapy

Published in Gene Therapy Weekly, March 15th, 2001

After previously demonstrating that they could use gene therapy to prevent heart damage in rabbits with congestive heart failure, Duke University Medical Center researchers have now gone one step further to use gene therapy to actually reverse the damage already done to the rabbits' heart tissue.

Also for the first time, the researchers reported they employed minimally invasive techniques to deliver the gene therapy, giving them hope that in the near future, the same approach could be viable in treating humans with heart failure, one of the most difficult groups of heart patients to treat.

The Duke team, led by Walter Koch, associate professor of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2001-03-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry